These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 8396087)
21. Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis. Guay DR; Craft JC J Intern Med; 1992 Mar; 231(3):295-301. PubMed ID: 1532615 [TBL] [Abstract][Full Text] [Related]
22. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia. Poirier R J Antimicrob Chemother; 1991 Feb; 27 Suppl A():109-16. PubMed ID: 1827096 [TBL] [Abstract][Full Text] [Related]
23. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. Roord JJ; Wolf BH; Gossens MM; Kimpen JL Antimicrob Agents Chemother; 1996 Dec; 40(12):2765-8. PubMed ID: 9124837 [TBL] [Abstract][Full Text] [Related]
24. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis. Gotfried M; Busman TA; Norris S; Notario GF Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699 [TBL] [Abstract][Full Text] [Related]
25. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group. Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958 [TBL] [Abstract][Full Text] [Related]
26. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. Kinasewitz G; Wood RG Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):872-7. PubMed ID: 1662636 [TBL] [Abstract][Full Text] [Related]
27. Clarithromycin in the treatment of bacterial relapses of chronic bronchitis. Dericoloso A; Sanduzzi A; Cuccurullo S; Sarno M; Bianco A; Moro RA Riv Eur Sci Med Farmacol; 1991; 13(5-6):275-83. PubMed ID: 1840282 [TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection. Adam D; Glaser-Caldow E; Wachter J; Brueckner OJ; Hein J; Kroemer B; Hirsch J Clin Ther; 2001 Apr; 23(4):585-95. PubMed ID: 11354392 [TBL] [Abstract][Full Text] [Related]
29. A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis. Aldons PM J Antimicrob Chemother; 1991 Feb; 27 Suppl A():101-8. PubMed ID: 1827095 [TBL] [Abstract][Full Text] [Related]
30. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin. Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620 [TBL] [Abstract][Full Text] [Related]
31. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis. Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742 [TBL] [Abstract][Full Text] [Related]
32. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia. Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191 [TBL] [Abstract][Full Text] [Related]
33. Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group. Felstead SJ; Daniel R J Int Med Res; 1991; 19(5):363-72. PubMed ID: 1660823 [TBL] [Abstract][Full Text] [Related]
34. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Wilson R; Schentag JJ; Ball P; Mandell L; Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408 [TBL] [Abstract][Full Text] [Related]
35. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Chodosh S; DeAbate CA; Haverstock D; Aneiro L; Church D Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475 [TBL] [Abstract][Full Text] [Related]
36. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients. Principi N; Esposito S Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275 [TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis. Fraschini F J Int Med Res; 1990; 18(2):171-6. PubMed ID: 2140331 [TBL] [Abstract][Full Text] [Related]
39. Comparison of once- and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infections. Allin D; James I; Zachariah J; Carr W; Cullen S; Middleton A; Newson P; Lytle T; Coles S Clin Ther; 2001 Dec; 23(12):1958-68. PubMed ID: 11813931 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis. Anzueto A; Fisher CL; Busman T; Olson CA Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]